Essai clinique
Récupéré
Publication
clinicaltrials.gov
Daniel Coury, Patient-Centered Outcomes Research Institute, University of California, Irvine, Holland Bloorview Kids Rehabilitation Hospital, University of Rochester, Nationwide Children's Hospital, Children's Hospital Medical Center, Cincinnati, University of Virginia, et al.
(2023).
AWARE: Management of ADHD in Autism Spectrum Disorder.
ClinicalTrials.gov.
Daniel Coury.
- Date de publication
-
01/10/2023
- Identifiant
-
NCT05916339
- Auteurs
-
Daniel Coury,
Patient-Centered Outcomes Research Institute,
University of California, Irvine,
Holland Bloorview Kids Rehabilitation Hospital,
University of Rochester,
Nationwide Children's Hospital,
Children's Hospital Medical Center, Cincinnati,
University of Virginia,
University of Alberta,
Massachusetts General Hospital,
MaineHealth,
University of Michigan,
University of Pittsburgh,
Children's Hospital of Philadelphia,
Children's Hospital Los Angeles
- Source
- ClinicalTrials.gov
- Type de référence
- clinical_trial
- Éditeur
- Daniel Coury
- Source de métadonnées
- clinicaltrials.gov
Résumé
This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents with autism. Using a sequential, multiple assignment randomization trial (SMART) design the study will not only assess these two medications but also the role of an increasingly popular class of ADHD medication, the alpha-2 agonists. Findings from this study will help improve clinicians' approach to medication selection and reduce the repeated trials of multiple medications that are current standard care.